Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Arg753Gln Polymorphisms in the Toll-Like Receptor 2 Gene are Associated with Cytomegalovirus Infection in Egyptian Bone Marrow Recipients

Author(s): Sobhy Hassab El-Nabi, Samia Sayed, Mohamed A. Abd-Elhafez, Mohamed Elfiky, Ahmed E. Abdel Moneim and Islam El-Garawani*

Volume 20, Issue 4, 2020

Page: [619 - 624] Pages: 6

DOI: 10.2174/1871530319666191018124710

Price: $65

Abstract

Background: Previous studies have shown that cytomegalovirus (CMV) induced innate immune response via activation of Toll-like receptor 2 (TLR2). The association between CMV among specific single-nucleotide polymorphisms (SNPs) in the TLR2 gene was also investigated.

Objective: This study investigated the relationship between specific SNPs in the TLR2 gene (G>A), TLR2-Arg753Gln (rs5743708), and CMV replication after bone marrow transplantation.

Methods: The TLR2-Arg753Gln SNP was genotyped in 181 patients after bone marrow transplantation: 83 and 98 patients with and without CMV infection, respectively. CMV load was determined in serially collected blood samples using real-time PCR. Genotyping was performed using specific sequence primer PCR (SSP-PCR), and the results were confirmed by restriction fragment length polymorphism (RFLP) analysis of the PCR-amplified fragments for GG (wild type), GA and AA identification.

Results: Roughly, 85% of the patients screened for the presence of the TLR2-Arg753Gln were GG homozygous, and 15% were GA heterozygous; no patients were homozygous for the mutant allele (A). The GA heterozygous allele was more frequent in the CMV-infected group after bone marrow transplantation.

Conclusion: To our knowledge, this is a novel observation that supports the notion that the functional missense mutation (TLR2-Arg753Gln polymorphism) is possibly associated with CMV replication after bone marrow transplantation. This suggests a role for TLR2 in the innate immune response of human CMV infection in Egyptian bone marrow recipients.

Keywords: Toll-like receptor 2, bone marrow transplantation, cytomegalovirus, single-nucleotide polymorphisms (SNPs), Arg753Gln, rs5743708.

« Previous Next »
Graphical Abstract

[1]
Schottstedt, V.; Blümel, J.; Burger, R.; Drosten, C.; Gröner, A.; Gürtler, L.; Heiden, M.; Hildebrandt, M.; Jansen, B.; Montag-Lessing, T.; Offergeld, R.; Pauli, G.; Seitz, R.; Schlenkrich, U.; Strobel, J.; Willkommen, H.; von König, C.H. Human Cytomegalovirus (HCMV) - Revised. Transfus. Med. Hemother., 2010, 37(6), 365-375.
[http://dx.doi.org/10.1159/000322141] [PMID: 21483467]
[2]
Chandler, S.H.; McDougall, J.K. Comparison of restriction site polymorphisms among clinical isolates and laboratory strains of human cytomegalovirus. J. Gen. Virol., 1986, 67(Pt 10), 2179-2192.
[http://dx.doi.org/10.1099/0022-1317-67-10-2179] [PMID: 2876051]
[3]
Walker, C.M.; van Burik, J.A.; De For, T.E.; Weisdorf, D.J. Cytomegalovirus infection after allogeneic transplantation: comparison of cord blood with peripheral blood and marrow graft sources. Biol. Blood Marrow Transplant., 2007, 13(9), 1106-1115.
[http://dx.doi.org/10.1016/j.bbmt.2007.06.006]
[4]
Macarski, E.S.; Shenk, T.; Pass, R.F. Cytomegaloviruses.Fields’ Virology; Fields, B.N.; Knipe, D.M; Howley, P.M., Ed.; Lippincott Williams & Wilkins: Philadelphia, USA, 2007, Vol. 1, pp. 2701-2772.
[5]
Griffiths, P.D. Cytomegalovirus.Principles and Practice of Clinical Virology; Zuckerman, A.J.; Banatvala, J.E; Pattison, J.R., Ed.; John Wiley and Sons: London, UK, 2000, pp. 79-116.
[6]
Sissons, J.G.; Carmichael, A.J. Clinical aspects and management of cytomegalovirus infection. J. Infect., 2002, 44(2), 78-83.
[http://dx.doi.org/10.1053/jinf.2001.0949] [PMID: 12076065]
[7]
Meyers, J.D.; Flournoy, N.; Thomas, E.D. Risk factors for cytomegalovirus infection after human marrow transplantation. J. Infect. Dis., 1986, 153(3), 478-488.
[http://dx.doi.org/10.1093/infdis/153.3.478] [PMID: 3005424]
[8]
Winston, D.J.; Huang, E.S.; Miller, M.J.; Lin, C.H.; Ho, W.G.; Gale, R.P.; Champlin, R.E. Molecular epidemiology of cytomegalovirus infections associated with bone marrow transplantation. Ann. Intern. Med., 1985, 102(1), 16-20.
[http://dx.doi.org/10.7326/0003-4819-102-1-16] [PMID: 2981496]
[9]
Delneste, Y.; Beauvillain, C.; Jeannin, P. [Innate immunity: structure and function of TLRs]. Med. Sci. (Paris), 2007, 23(1), 67-73.
[10]
Rock, F.L.; Hardiman, G.; Timans, J.C.; Kastelein, R.A.; Bazan, J.F. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA, 1998, 95(2), 588-593.
[http://dx.doi.org/10.1073/pnas.95.2.588] [PMID: 9435236]
[11]
Chen, Y.C.; Hsiao, C.C.; Chen, C.J.; Chin, C.H.; Liu, S.F.; Wu, C.C.; Eng, H.L.; Chao, T.Y.; Tsen, C.C.; Wang, Y.H.; Lin, M.C. Toll-like receptor 2 gene polymorphisms, pulmonary tuberculosis, and natural killer cell counts. BMC Med. Genet., 2010, 11, 17.
[http://dx.doi.org/10.1186/1471-2350-11-17]
[12]
Brown, R.A.; Gralewski, J.H.; Eid, A.J.; Knoll, B.M.; Finberg, R.W.; Razonable, R.R. R753Q single-nucleotide polymorphism impairs toll-like receptor 2 recognition of hepatitis C virus core and nonstructural 3 proteins. Transplantation, 2010, 89(7), 811-815.
[http://dx.doi.org/10.1097/TP.0b013e3181cbac18] [PMID: 20090572]
[13]
Eid, A.J.; Brown, R.A.; Paya, C.V.; Razonable, R.R. Association between toll-like receptor polymorphisms and the outcome of liver transplantation for chronic hepatitis C virus. Transplantation, 2007, 84(4), 511-516.
[http://dx.doi.org/10.1097/01.tp.0000276960.35313.bf] [PMID: 17713436]
[14]
Lorenz, E.; Mira, J.P.; Cornish, K.L.; Arbour, N.C.; Schwartz, D.A. A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection. Infect. Immun., 2000, 68(11), 6398-6401.
[http://dx.doi.org/10.1128/IAI.68.11.6398-6401.2000] [PMID: 11035751]
[15]
Cedola, M.; Chiani, Y.; Pretre, G.; Alberdi, L.; Vanasco, B.; Gomez, R.M. Association of Toll-like receptor 2 Arg753Gln and Toll-like receptor 1 Ile602Ser single-nucleotide polymorphisms with leptospirosis in an Argentine population. Acta Trop., 2015, 146, 73-80.
[16]
Jablonska, A.; Paradowska, E.; Studzinska, M.; Suski, P.; Nowakowska, D.; Wisniewska-Ligier, M.; Wozniakowska-Gesicka, T.; Wilczynski, J.; Lesnikowski, Z.J. Relationship between toll-like receptor 2 Arg677Trp and Arg753Gln and toll-like receptor 4 Asp299Gly polymorphisms and cytomegalovirus infection. Int. J. Infect. Dis., 2014, 25, 11-15.http://dx.doi.org/S1201-9712(14)01474-X
[17]
Gao, Y.; Xiao, H.; Wang, Y.; Xu, F. Association of single-nucleotide polymorphisms in toll-like receptor 2 gene with asthma susceptibility: A meta-analysis. Medicine (Baltimore), 2017, 96(20) e6822
[http://dx.doi.org/10.1097/MD.0000000000006822] [PMID: 28514297]
[18]
Aljanabi, SM.; Martinez, I. Universal and rapid salt-extraction of high quality genomic DNA for PCR-based techniques. Nucleic Acids Res., 1997, 25(22), 4692-4693.
[19]
Compton, T.; Kurt-Jones, E.A.; Boehme, K.W.; Belko, J.; Latz, E.; Golenbock, D.T.; Finberg, R.W. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol., 2003, 77(8), 4588-4596.
[http://dx.doi.org/10.1128/JVI.77.8.4588-4596.2003] [PMID: 12663765]
[20]
Karaca, N.; Ozturk, G.; Gerceker, B.T.; Turkmen, M.; Berdeli, A. TLR2 and TLR4 gene polymorphisms in Turkish vitiligo patients. J. Eur. Acad. Dermatol. Venereol., 2013, 27(1), e85-e90.
[http://dx.doi.org/10.1111/j.1468-3083.2012.04514.x] [PMID: 22429552]
[21]
Juckem, L.K.; Boehme, K.W.; Feire, A.L.; Compton, T. Differential initiation of innate immune responses induced by human cytomegalovirus entry into fibroblast cells. J. Immunol., 2008, 180(7), 4965-4977.
[22]
Ariza, M.E.; Glaser, R.; Kaumaya, P.T.; Jones, C.; Williams, M.V. The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J. Immunol., 2009, 182(2), 851-859.
[23]
Xiong, Y.; Song, C.; Snyder, G.A.; Sundberg, E.J.; Medvedev, A.E. R753Q polymorphism inhibits Toll-like receptor (TLR) 2 tyrosine phosphorylation, dimerization with TLR6, and recruitment of myeloid differentiation primary response protein 88. J. Biol. Chem., 2012, 287(45), 38327-38337.
[24]
Kijpittayarit, S.; Eid, A.J.; Brown, R.A.; Paya, C.V.; Razonable, R.R. Relationship between Toll-like receptor 2 polymorphism and cytomegalovirus disease after liver transplantation. Clin. Infect. Dis., 2007, 44(10), 1315-1320.
[http://dx.doi.org/10.1086/514339]
[25]
Wujcicka, W.; Paradowska, E.; Studzińska, M.; Gaj, Z.; Wilczyński, J.; Leśnikowski, Z.; Nowakowska, D. TLR9 2848 GA heterozygotic status possibly predisposes fetuses and newborns to congenital infection with human cytomegalovirus. PLoS One, 2015, 10(4) e0122831
[http://dx.doi.org/10.1371/journal.pone.0122831] [PMID: 25844529]
[26]
von Aulock, S.; Schröder, N.W.; Traub, S.; Gueinzius, K.; Lorenz, E.; Hartung, T.; Schumann, R.R.; Hermann, C. Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses. Infect. Immun., 2004, 72(3), 1828-1831.
[http://dx.doi.org/10.1128/IAI.72.3.1828-1831.2004] [PMID: 14977997]
[27]
Lien, E.; Ingalls, R.R. Toll-like receptors. Crit. Care Med., 2002, 30(1), S1-S11.
[http://dx.doi.org/10.1097/00003246-200201001-00001]
[28]
Schröder, N.W.; Hermann, C.; Hamann, L.; Göbel, U.B.; Hartung, T.; Schumann, R.R. High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR. J. Mol. Med. (Berl.), 2003, 81(6), 368-372.
[http://dx.doi.org/10.1007/s00109-003-0443-x] [PMID: 12743710]

Rights & Permissions Print Cite
Article Metrics
6
© 2024 Bentham Science Publishers | Privacy Policy